Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial membrane energetics and transport systems represent a complex network of proteins and pathways essential for the survival, growth, and pathogenesis of Mycobacterium tuberculosis. This target category includes the oxidative phosphorylation machinery, such as the electron transport chain (ETC) and ATP synthase, which collectively maintain the proton motive force and generate cellular ATP (Cook et al., 2017). It also encompasses vital membrane transporters like MmpL3, which is responsible for the export of trehalose monomycolate required for cell wall assembly (Tahlan et al., 2012). Drugs targeting these systems, such as Bedaquiline (inhibiting ATP synthase) and Telacebec (inhibiting the cytochrome bcc complex), have revolutionized the treatment of multi-drug resistant tuberculosis (Andries et al., 2005; Pethe et al., 2013). These systems are particularly attractive targets because they are required not only during active replication but also for the persistence of dormant mycobacteria in host tissues (Bald & Koul, 2010). However, therapeutic intervention in these pathways often requires careful monitoring for safety concerns like cardiotoxicity and complex drug-drug interactions.
Inhibition of ATP synthase, inhibition of the cytochrome bcc-aa3 complex, disruption of the proton motive force, and inhibition of MmpL3-mediated mycolic acid transport.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial membrane energetics and transport systems.